Functional Determinants of Metastatic Dormancy

转移休眠的功能决定因素

基本信息

项目摘要

SUMMARY. The majority of cancer patients die of metastases originating from disseminated cancer cells (DCCs), years and decades after treatment. This has been linked to the ability of DCCs to survive in a dormant state and evade therapies. Our long-term goal is to understand dormancy of DCCs as a systemic disease mechanism to target them and prevent relapse. Our overarching hypothesis is that complementary mechanism between gene programs in primary lesions and target organs niche signals, converge to instruct DCCs in target organs to enter dormancy via quiescence, pluripotency and survival programs. We further hypothesize that such signals can be manipulated to suppress metastasis. Using epithelial cancer models we have discovered that early dissemination spawns mesenchymal-like (M-Like) dormant breast cancer (BC) DCCs. We also discovered that hypoxia in advanced primary tumors can prime DCC precursors to activate quiescence programs and enter dormancy in target organs. Importantly, M-like early DCC precursors also display a strong hypoxia response. Both early and late DCCs were found to respond to retinoic acid, WNT5A, BMP7 and TGF2 signals derived from stromal target organ niches. These activate transcriptional programs integrated by ZFP281 (a novel early DCC dormancy regulator) and NR2F1 to induce dormancy. Our new aims build on these findings and explore three significant new discoveries: 1) Hypoxia signals in early and late primary lesions turn on quiescence programs that epigenetically imprint DCC precursors to enter dormancy when they arrive to target organs, 2) early or late DCCs that arrive to the bone marrow (BM) enter dormancy in response to TGF2 and BMP7 produced by Nestin+/NG2+ mesenchymal stem cells (N+MSCs), which control hematopoietic stem cells (HSCs) dormancy; loss of N+MSCs or TGF2 expression in these MSCs led to bone metastasis and 3), in lungs, early and late DCCs reside in pro-dormancy niches orchestrated by alveolar macrophages (AMs), which when depleted awaken dormant DCCs. We propose to study how signals from primary lesion hypoxia along with BM and lung homeostatic niches are integrated to keep DCCs dormant. The specific aims are: AIM 1. Determine how hypoxia primes DCCs for dormancy. AIM 2. Determine how NG2+/Nestin+ MSCs orchestrate dormancy niches and how aging affects these mechanisms. AIM 3. Determine how tissue resident lung alveolar macrophages (AMs) dictate DCC fate and how aging impacts the function of these niches. Our proposal will integrate how primary lesions (early or late) may pre-program DCCs for dormancy in defined target organ niches which further reinforce dormancy via specific cues, which may be affected by aging. This approach will aid the design of rational methods to predict dormancy onset, monitor residual cancer and develop therapies to induce and maintain dormancy or eradicate minimal residual cancer.
摘要大多数癌症患者死于源自播散性癌细胞的转移 (DCC),治疗后数年和数十年。这与DCC在休眠状态下生存的能力有关。 陈述和逃避治疗。我们的长期目标是了解作为一种系统性疾病的DCC休眠 针对他们并防止复发的机制。我们的总体假设是, 原发性病变和靶器官生态位信号中的基因程序之间的关系,收敛到指导DCC在 靶器官通过静止、多能性和存活程序进入休眠。我们进一步假设 这些信号可以被操纵来抑制转移。使用上皮癌模型, 发现早期传播产生间充质样(M样)休眠乳腺癌(BC)DCC。 我们还发现,在晚期原发性肿瘤中,缺氧可以使DCC前体活化, 静止程序并在靶器官中进入休眠。重要的是,M样早期DCC前体也 表现出强烈的缺氧反应发现早期和晚期DCC都对维甲酸、WNT 5A、 BMP 7和TGF β 2信号来源于基质靶器官小生境。这些激活转录程序 ZFP 281(一种新的DCC早期休眠调节剂)和NR 2F 1整合诱导休眠。我们的新目标 在这些发现的基础上,探索了三个重要的新发现:1)早期和晚期缺氧信号 原发病变开启静止程序,表观遗传印记DCC前体进入休眠 当它们到达靶器官时,2)到达骨髓(BM)的早期或晚期DCC在 巢蛋白+/NG 2+间充质干细胞(N+ MSC)产生的TGF β 2和BMP 7的反应,这些细胞控制 造血干细胞(HSC)休眠;在这些MSC中的N+ MSC或TGF β 2表达的丧失导致骨 转移和3),在肺,早期和晚期DCC驻留在由肺泡 巨噬细胞(AM),当耗尽唤醒休眠的DCC。我们打算研究来自 原发性病变缺氧沿着BM和肺稳态小生境被整合以保持DCC休眠。的 具体目标是:目标1。确定缺氧如何使DCC休眠。AIM 2.确定如何 NG 2 +/Nestin+ MSC协调休眠壁龛以及衰老如何影响这些机制。AIM 3. 确定组织驻留肺泡巨噬细胞(AM)如何决定DCC的命运以及衰老如何影响DCC。 这些小生境的功能。我们的建议将整合原发性病变(早期或晚期)如何预编程DCC 对于在限定的目标器官小生境中的休眠,其通过特定的线索进一步加强休眠, 受老化影响。这种方法将有助于设计合理的方法来预测休眠开始,监测 并开发治疗方法以诱导和维持休眠或根除最小残留癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julio A. Aguirre-Ghiso其他文献

Models, mechanisms and clinical evidence for cancer dormancy
癌症休眠的模型、机制和临床证据
  • DOI:
    10.1038/nrc2256
  • 发表时间:
    2007-11-01
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Julio A. Aguirre-Ghiso
  • 通讯作者:
    Julio A. Aguirre-Ghiso
Targeting PERK Arm of Unfolded Protein Response Helps to Eliminate Therapy-Induced Residual Senescent-like Acute Myeloid Leukemia Cells
  • DOI:
    10.1182/blood-2024-203451
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Gowri Poigaialwar;Sumiko Takao;Sovira Chaudhry;Laura K. Schmalbrock;Varun Gupta;Alex Kentsis;Julio A. Aguirre-Ghiso;Marina Konopleva;Maria S. Sosa;Anna Skwarska
  • 通讯作者:
    Anna Skwarska

Julio A. Aguirre-Ghiso的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julio A. Aguirre-Ghiso', 18)}}的其他基金

Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
  • 批准号:
    10525056
  • 财政年份:
    2022
  • 资助金额:
    $ 61.06万
  • 项目类别:
Functional Determinants of Metastatic Dormancy
转移休眠的功能决定因素
  • 批准号:
    10516864
  • 财政年份:
    2022
  • 资助金额:
    $ 61.06万
  • 项目类别:
Functional Determinants of Metastatic Dormancy
转移休眠的功能决定因素
  • 批准号:
    10678829
  • 财政年份:
    2022
  • 资助金额:
    $ 61.06万
  • 项目类别:
Immune Regulation of Disseminated Cancer Cell Dormancy
播散性癌细胞休眠的免疫调节
  • 批准号:
    10201082
  • 财政年份:
    2021
  • 资助金额:
    $ 61.06万
  • 项目类别:
Immune Regulation of Disseminated Cancer Cell Dormancy
播散性癌细胞休眠的免疫调节
  • 批准号:
    10513907
  • 财政年份:
    2021
  • 资助金额:
    $ 61.06万
  • 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
  • 批准号:
    10645058
  • 财政年份:
    2020
  • 资助金额:
    $ 61.06万
  • 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
  • 批准号:
    10226338
  • 财政年份:
    2020
  • 资助金额:
    $ 61.06万
  • 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
  • 批准号:
    10414811
  • 财政年份:
    2020
  • 资助金额:
    $ 61.06万
  • 项目类别:
Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
  • 批准号:
    9924485
  • 财政年份:
    2017
  • 资助金额:
    $ 61.06万
  • 项目类别:
Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
  • 批准号:
    9502259
  • 财政年份:
    2017
  • 资助金额:
    $ 61.06万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 61.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了